Loading...

Tayek John A

Title(s)Associate Professor, General Internal Medicine
SchoolThe Lundquist Institute for Biomedical Innovation
vCardDownload vCard
    Other Positions
    Title(s)Professor, Medicine


    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Cherukuri L, Gewirtz G, Osea K, Tayek JA. Vitamin A treatment for severe sepsis in humans; a prospective randomized double blind placebo-controlled clinical trial. Clin Nutr ESPEN. 2019 02; 29:49-51. PMID: 30661700.
      View in: PubMed
    2. Tayek CJ, Cherukuri L, Hamal S, Tayek JA. Importance of fasting blood glucose goals in the management of type 2 diabetes mellitus: a review of the literature and a critical appraisal. J Diabetes Metab Disord Control. 2018; 5(4):113-117. PMID: 31404422.
      View in: PubMed
    3. Cherukuri L, Smith MS, Tayek JA. The durability of oral diabetic medications: Time to A1c baseline and a review of common oral medications used by the primary care provider. Endocrinol Diabetes Metab J. 2018 Sep; 2(3). PMID: 30370022.
      View in: PubMed
    4. Budoff MJ, Tayek J. Coronary Artery Calcium Progression: Increasing CAC Is Associated With Increased Events. JACC Cardiovasc Imaging. 2018 03; 11(3):517-518. PMID: 29519342.
      View in: PubMed
    5. Tayek JA, Danese PNN, Smith MS. Safety of Degludec versus Glargine in Type 2 Diabetes. N Engl J Med. 2017 11 16; 377(20):1994-5. PMID: 29143514.
      View in: PubMed
    6. Ghanaat F, Tayek JA. Weight loss and diabetes are new risk factors for the development of invasive aspergillosis infection in non-immunocompromized humans. Clin Pract (Lond). 2017; 14(5 Spec Iss):296-301. PMID: 29670744.
      View in: PubMed
    7. Lopez JL, Tayek JA. Voriconazole-Induced Hepatitis via Simvastatin- and Lansoprazole-Mediated Drug Interactions: A Case Report and Review of the Literature. Drug Metab Dispos. 2016 Jan; 44(1):124-6. PMID: 26502771.
      View in: PubMed
    8. Shah A, Miller CJ, Nast CC, Adams MD, Truitt B, Tayek JA, Tong L, Mehtani P, Monteon F, Sedor JR, Clinkenbeard EL, White K, Mehrotra R, LaPage J, Dickson P, Adler SG, Iyengar SK. Severe vascular calcification and tumoral calcinosis in a family with hyperphosphatemia: a fibroblast growth factor 23 mutation identified by exome sequencing. Nephrol Dial Transplant. 2014 Dec; 29(12):2235-43. PMID: 25378588.
      View in: PubMed
    9. Rattanasompattikul M, Molnar MZ, Lee ML, Dukkipati R, Bross R, Jing J, Kim Y, Voss AC, Benner D, Feroze U, Macdougall IC, Tayek JA, Norris KC, Kopple JD, Unruh M, Kovesdy CP, Kalantar-Zadeh K. Anti-Inflammatory and Anti-Oxidative Nutrition in Hypoalbuminemic Dialysis Patients (AIONID) study: results of the pilot-feasibility, double-blind, randomized, placebo-controlled trial. J Cachexia Sarcopenia Muscle. 2013 Dec; 4(4):247-57. PMID: 24052226.
      View in: PubMed
    10. Daga N, Nasir K, Hamirani Y, Tayek J, Bach P, Li D, Budoff MJ. Prevalence and severity of coronary artery calcium in young persons with diabetes. J Cardiovasc Comput Tomogr. 2013 Jul-Aug; 7(4):241-7. PMID: 24148777.
      View in: PubMed
    11. Tayek JA, Kalantar-Zadeh K. The extinguished BEACON of bardoxolone: not a Monday morning quarterback story. Am J Nephrol. 2013; 37(3):208-11. PMID: 23466901.
      View in: PubMed
    12. Patel SS, Molnar MZ, Tayek JA, Ix JH, Noori N, Benner D, Heymsfield S, Kopple JD, Kovesdy CP, Kalantar-Zadeh K. Serum creatinine as a marker of muscle mass in chronic kidney disease: results of a cross-sectional study and review of literature. J Cachexia Sarcopenia Muscle. 2013 Mar; 4(1):19-29. PMID: 22777757.
      View in: PubMed
    13. Madaj PM, Budoff MJ, Li D, Tayek JA, Karlsberg RP, Karpman HL. Identification of noncalcified plaque in young persons with diabetes: an opportunity for early primary prevention of coronary artery disease identified with low-dose coronary computed tomographic angiography. Acad Radiol. 2012 Jul; 19(7):889-93. PMID: 22542200.
      View in: PubMed
    14. Tayek CJ, Tayek JA. Diabetes patients and non-diabetic patients intensive care unit and hospital mortality risks associated with sepsis. World J Diabetes. 2012 Feb 15; 3(2):29-34. PMID: 22375163.
      View in: PubMed
    15. Kim S, Abboud HE, Pahl MV, Tayek J, Snyder S, Tamkin J, Alcorn H, Ipp E, Nast CC, Elston RC, Iyengar SK, Adler SG. Examination of association with candidate genes for diabetic nephropathy in a Mexican American population. Clin J Am Soc Nephrol. 2010 Jun; 5(6):1072-8. PMID: 20299368.
      View in: PubMed
    16. McKinnell J, Tayek JA. Short term treatment with clarithromycin resulting in colchicine-induced rhabdomyolysis. J Clin Rheumatol. 2009 Sep; 15(6):303-5. PMID: 19734738.
      View in: PubMed
    17. Abdelhafiz AH, Myint MP, Tayek JA, Wheeldon NM. Anemia, hypoalbuminemia, and renal impairment as predictors of bleeding complications in patients receiving anticoagulation therapy for nonvalvular atrial fibrillation: a secondary analysis. Clin Ther. 2009 Jul; 31(7):1534-9. PMID: 19695402.
      View in: PubMed
    18. Zisman DA, Kawut SM, Lederer DJ, Belperio JA, Lynch JP, Schwarz MI, Tayek JA, Reuben DB, Karlamangla AS. Serum albumin concentration and waiting list mortality in idiopathic interstitial pneumonia. Chest. 2009 Apr; 135(4):929-935. PMID: 19017875.
      View in: PubMed
    19. Tayek JA. Stents versus bypass grafting for left main coronary artery disease. N Engl J Med. 2008 Jul 24; 359(4):424; author reply 425. PMID: 18655244.
      View in: PubMed
    20. Ford JS, Tayek JA. Lipophilicity and cardiovascular outcome in patients with CHF. Am Heart J. 2008 Aug; 156(2):e7; author reply e9. PMID: 18657645.
      View in: PubMed
    21. Tayek JA. Multifactorial intervention and mortality in type 2 diabetes. N Engl J Med. 2008 May 22; 358(21):2292; author reply 2292-3. PMID: 18504827.
      View in: PubMed
    22. Tayek JA. Early hyperglycemia and intravenous insulin. Neurocrit Care. 2008; 9(3):409-10. PMID: 18363041.
      View in: PubMed
    23. Segal JL, Thompson JF, Tayek JA. Effects of long-term 4-aminopyridine therapy on glucose tolerance and glucokinetics in patients with spinal cord injury. Pharmacotherapy. 2007 Jun; 27(6):789-92. PMID: 17542761.
      View in: PubMed
    24. Tayek JA. Don't throw the baby out with the bath water: mortality with combination metformin and sulfonylurea. Diabetes Metab Res Rev. 2007 Feb; 23(2):85-6. PMID: 17262894.
      View in: PubMed
    25. Tayek JA. Comment on: Evans JMM, Ogston SA, Emslie-Smith A, Morris AD (2006) risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin. Diabetologia 49:930-936. Diabetologia. 2006 Nov; 49(11):2807-8. PMID: 16955252.
      View in: PubMed
    26. Tayek J. Comment on "Mean glucose level is not an independent risk factor for mortality in mixed ICU patients" by Ligtenberg et al. Intensive Care Med. 2006 Oct; 32(10):1658-9; author reply 1660. PMID: 16826381.
      View in: PubMed
    27. Tayek JA. A1c and mortality: an unexpected relationship in patients with advanced heart failure. Am Heart J. 2006 Jul; 152(1):e5; author reply e7. PMID: 16824822.
      View in: PubMed
    28. Tayek JA. Detailing and clarifying cortisol's role in the metabolic response to injury. Crit Care Med. 2005 Jul; 33(7):1648-50. PMID: 16003080.
      View in: PubMed
    29. Tayek JA. Lower cortisol concentrations in patients with liver disease: more adrenal failure or more confusion? Crit Care Med. 2005 Jun; 33(6):1431-2. PMID: 15942373.
      View in: PubMed
    30. Ghanaat F, Tayek JA. Growth hormone administration increases glucose production by preventing the expected decrease in glycogenolysis seen with fasting in healthy volunteers. Metabolism. 2005 May; 54(5):604-9. PMID: 15877290.
      View in: PubMed
    31. Feinglos M, Dailey G, Cefalu W, Osei K, Tayek J, Canovatchel W, Chaiken R, Kourides I. Effect on glycemic control of the addition of 2.5 mg glipizide GITS to metformin in patients with T2DM. Diabetes Res Clin Pract. 2005 May; 68(2):167-75. PMID: 15860246.
      View in: PubMed
    32. Tayek J. Atorvastatin reduced coronary and stroke events in patients with hypertension and without dyslipidemia. ACP J Club. 2004 Mar-Apr; 140(2):A16; author reply A16. PMID: 15122876.
      View in: PubMed
    33. Bavirti S, Ghanaat F, Tayek JA. Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control. Endocr Pract. 2003 Nov-Dec; 9(6):487-93. PMID: 14715475.
      View in: PubMed
    34. Apostol AT, Tayek JA. A decrease in glucose production is associated with an increase in plasma citrulline response to oral arginine in normal volunteers. Metabolism. 2003 Nov; 52(11):1512-6. PMID: 14624416.
      View in: PubMed
    35. Manglik S, Flores E, Lubarsky L, Fernandez F, Chhibber VL, Tayek JA. Glucocorticoid insufficiency in patients who present to the hospital with severe sepsis: a prospective clinical trial. Crit Care Med. 2003 Jun; 31(6):1668-75. PMID: 12794402.
      View in: PubMed
    36. Bavirti S, Tayek JA. Low-dose oral glyburide reduces glucose production rates in patients with impaired fasting glucose. Metabolism. 2003 Apr; 52(4):407-12. PMID: 12701050.
      View in: PubMed
    37. Huynh NT, Tayek JA. Oral arginine reduces systemic blood pressure in type 2 diabetes: its potential role in nitric oxide generation. J Am Coll Nutr. 2002 Oct; 21(5):422-7. PMID: 12356784.
      View in: PubMed
    38. Subbiah V, Tayek JA. Tetany secondary to the use of a proton-pump inhibitor. Ann Intern Med. 2002 Aug 06; 137(3):219. PMID: 12160379.
      View in: PubMed
    39. Richardson AP, Tayek JA. Type 2 diabetic patients may have a mild form of an injury response: a clinical research center study. Am J Physiol Endocrinol Metab. 2002 Jun; 282(6):E1286-90. PMID: 12006358.
      View in: PubMed
    40. Tayek JA. Is weight loss a cure for type 2 diabetes? Diabetes Care. 2002 Feb; 25(2):397-8. PMID: 11815518.
      View in: PubMed
    41. Khani S, Tayek JA. Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clin Sci (Lond). 2001 Dec; 101(6):739-47. PMID: 11724664.
      View in: PubMed
    42. Novoa-Takara L, Cornford M, Williams C, Tayek JA. Lymphocytic hypophysitis in a man presenting with hypercalcemia. Am J Med Sci. 2001 Mar; 321(3):206-8. PMID: 11269800.
      View in: PubMed
    43. Chhibber VL, Soriano C, Tayek JA. Effects of low-dose and high-dose glucagon on glucose production and gluconeogenesis in humans. Metabolism. 2000 Jan; 49(1):39-46. PMID: 10647062.
      View in: PubMed
    44. Katz J, Tayek JA. Recycling of glucose and determination of the Cori Cycle and gluconeogenesis. Am J Physiol. 1999 09; 277(3):E401-7. PMID: 10484349.
      View in: PubMed
    45. Katz J, Tayek JA. Gluconeogenesis and the Cori cycle in 12-, 20-, and 40-h-fasted humans. Am J Physiol. 1998 09; 275(3):E537-42. PMID: 9725823.
      View in: PubMed
    46. Manglik S, Cobanov B, Flores G, Nadjafi R, Tayek JA. Serum insulin but not leptin is associated with spontaneous and growth hormone (GH)-releasing hormone-stimulated GH secretion in normal volunteers with and without weight loss. Metabolism. 1998 Sep; 47(9):1127-33. PMID: 9751243.
      View in: PubMed
    47. Tayek JA, Katz J. Glucose production, recycling, Cori cycle, and gluconeogenesis in humans: relationship to serum cortisol. Am J Physiol. 1997 Mar; 272(3 Pt 1):E476-84. PMID: 9124555.
      View in: PubMed
    48. Tayek JA, Manglik S, Abemayor E. Insulin secretion, glucose production, and insulin sensitivity in underweight and normal-weight volunteers, and in underweight and normal-weight cancer patients: a Clinical Research Center study. Metabolism. 1997 Feb; 46(2):140-5. PMID: 9030818.
      View in: PubMed
    49. Tayek JA, Katz J. Glucose production, recycling, and gluconeogenesis in normals and diabetics: a mass isotopomer [U-13C]glucose study. Am J Physiol. 1996 Apr; 270(4 Pt 1):E709-17. PMID: 8928779.
      View in: PubMed
    50. Tayek JA. Effects of tumor necrosis factor alpha on skeletal muscle amino acid metabolism studied in-vivo. J Am Coll Nutr. 1996 Apr; 15(2):164-8. PMID: 8778147.
      View in: PubMed
    51. Tayek JA, Sutter L, Manglik S, Lillington LB, Grosvenor M, Chlebowski RT. Altered metabolism and mortality in patients with colon cancer receiving chemotherapy. Am J Med Sci. 1995 Aug; 310(2):48-55. PMID: 7631642.
      View in: PubMed
    52. Tayek JA. Reduced non-oxidative glucose utilization in cancer patients is associated with a low triiodothyronine concentration. J Am Coll Nutr. 1995 Aug; 14(4):341-8. PMID: 8568110.
      View in: PubMed
    53. Tayek JA, Brasel JA. Failure of anabolism in malnourished cancer patients receiving growth hormone: a clinical research center study. J Clin Endocrinol Metab. 1995 Jul; 80(7):2082-7. PMID: 7608259.
      View in: PubMed
    54. Fouque D, Tayek JA, Kopple JD. Altered mental function during intravenous infusion of recombinant human insulin-like growth factor 1. JPEN J Parenter Enteral Nutr. 1995 May-Jun; 19(3):231-3. PMID: 8551653.
      View in: PubMed
    55. Tayek JA, Atienza VJ. Pituitary-adrenal axis function in systemic inflammatory response syndrome. Endocrine. 1995 May; 3(5):315-8. PMID: 21153181.
      View in: PubMed
    56. Tayek JA. Low-dose oral glyburide reduces fasting blood glucose by decreasing hepatic glucose production in healthy volunteers without increasing carbohydrate oxidation. Am J Med Sci. 1995 Mar; 309(3):134-9. PMID: 7879817.
      View in: PubMed
    57. Tayek JA. A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. J Am Coll Nutr. 1992 Aug; 11(4):445-56. PMID: 1506607.
      View in: PubMed
    58. Tayek JA, Bergner EA, Lee WP. Correction of glucose carbon recycling for the determination of 'true' hepatic glucose production rates by (1-13C1)glucose. Biol Mass Spectrom. 1991 Apr; 20(4):186-90. PMID: 2054392.
      View in: PubMed
    59. Tayek JA, Heber D, Byerley LO, Steiner B, Rajfer J, Swerdloff RS. Nutritional and metabolic effects of gonadotropin-releasing hormone agonist treatment for prostate cancer. Metabolism. 1990 Dec; 39(12):1314-9. PMID: 2123281.
      View in: PubMed
    60. Tayek JA, Brasel JA. Effects of tumor necrosis factor alpha on skeletal muscle and Walker 256 carcinosarcoma protein metabolism studied in vivo. Cancer Res. 1990 May 01; 50(9):2765-8. PMID: 2328503.
      View in: PubMed
    61. Tayek JA, Bulcavage L, Chlebowski RT. Relationship of hepatic glucose production to growth hormone and severity of malnutrition in a population with colorectal carcinoma. Cancer Res. 1990 Apr 01; 50(7):2119-22. PMID: 2317802.
      View in: PubMed
    62. Tayek JA, Bistrian B, Sheard NF, Zeisel SH, Blackburn GL. Abnormal liver function in malnourished patients receiving total parenteral nutrition: a prospective randomized study. J Am Coll Nutr. 1990 Feb; 9(1):76-83. PMID: 2106545.
      View in: PubMed